axel gräwingholt, md discusses the future of breast cancer risk
Published 3 years ago • 29 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
0:36
axel gräwingholt - what is the clinical value of profound ai risk?
-
0:43
axel grawingholt, md - discover the power of profound ai for dbt
-
1:10
axel gräwingholt - what are the advantages of short-term risk assessment?
-
12:01
dr. axel gräwingholt | profound ai and profound ai risk clinical case study
-
0:30
axel gräwingholt - what are the advantages of short-term risk assessment?
-
1:29
axel gräwingholt | case study
-
1:10
mark traill, md – advantages of icad’s risk assessment
-
1:18
axel gräwingholt - why do clinicians need a risk assessment tool?
-
1:14
axel grawingholt – short term risk patient communication
-
0:32
axel gräwingholt - how does profound ai risk work?
-
0:46
alex gräwingholt, md – improved review for dbt
-
9:27
profound ai solutions introduction & clinical case with dr. gräwingholt, radiologist, paderborn, de
-
0:32
axel gräwingholt - what is interval cancer?
-
0:40
per hall, phd, md - profound ai risk
-
0:52
discover the mechanism of how the mmtv-like virus raises cancer risk by manipulating our genetics
-
0:57
can you drink alcohol after cancer?
-
16:43
dr. gräwingholt - dbt and interval cancers presentation